Anti-Mouse CD279 (PD-1) – Purified In vivo PLATINUM™ Functional Grade

Pricing & Details

Clone
29F.1A12
Formats AvailableView All
Product Type
Monoclonal Antibody
Alternate Names
PD1, Programmed Death-1, CD279
Isotype
Rat
IgG2a κ
Prod No.
Size
Price
Avail.
Qty
Add to cart
P378-1mg
1.0 mg
$198.00
In stock
P378-5mg
5.0 mg
$355.00
In stock
P378-25mg
25 mg
$995.00
In stock
P378-50mg
50 mg
$1,500.00
In stock
P378-100mg
100 mg
$2,220.00
In stock

Data

Antibody Details

Reactivity Species
Mouse
Host Species
Rat
Immunogen
PD-1 cDNA followed by PD-1-Ig fusion protein
Product Concentration
≥ 2.0 mg/ml
Formulation
This Low Endotoxin Functional Formulation, PLATINUM antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (PBS) pH 7.2 - 7.4, 150 mM NaCl with no carrier protein, potassium or preservatives added.
Product Preparation
Functional grade preclinical antibodies are manufactured in an animal free facility using only In vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Pathogen Testing
To protect mouse colonies from infection by pathogens and to assure that experimental preclinical data is not affected by such pathogens, all of Leinco’s Purified Functional PLATINUM™ antibodies are tested and guaranteed to be negative for all pathogens in the IDEXX IMPACT I Mouse Profile.
Storage and Handling
Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
Other Applications Reported In Literature
CyTOF®
Each investigator should determine their own optimal working dilution for specific applications.

Description

Specificity
Clone 29F.1A12 recognizes an epitope on mouse PD-1.
Antigen Distribution
PD-1 is expressed on a subset of CD4-CD8- thymocytes, and on activated T and B cells.
Background
PD-1 is a 50-55 kD member of the B7 Ig superfamily. PD-1 is also a member of the extended CD28/CTLA-4 family of T cell regulators and is suspected to play a role in lymphocyte clonal selection and peripheral tolerance. The ligands of PD-1 are PD-L1 and PD-L2, and are also members of the B7 Ig superfamily. PD-1 and its ligands negatively regulate immune responses. PD-L1, or B7-Homolog 1, is a 40 kD type I transmembrane protein that has been reported to costimulate T cell growth and cytokine production. The interaction of PD-1 with its ligand PD-L1 is critical in the inhibition of T cell responses that include T cell proliferation and cytokine production. PD-L1 has increased expression in several cancers. Inhibition of the interaction between PD-1 and PD-L1 can serve as an immune checkpoint blockade by improving T-cell responses In vitro and mediating preclinical antitumor activity. Within the field of checkpoint inhibition, combination therapy using anti-PD1 in conjunction with anti-CTLA4 has significant therapeutic potential for tumor treatments. PD-L2 is a 25 kD type I transmembrane ligand of PD-1. Via PD-1, PD-L2 can serve as a coinhibitor of T cell functions. Regulation of T cell responses, including enhanced T cell proliferation and cytokine production, can result from mAbs that block the PD-L2 and PD-1 interaction.

Antigen Details

Protein Family
PD-1
Ligand/Receptor
B7-H1 (PD-L1) & B7-DC (PD-L2)
Function
Lymphocyte clonal selection, peripheral tolerance
NCBI Gene Bank ID
Flow Cytometry
General Western Blot Protocol

Formats Available

Products are for research use only. Not for use in diagnostic or therapeutic procedures.